Catalent Experts to Discuss Supply Chain for New Modalities, and Direct-to-Patient Clinical Supply for Decentralized Trials at GCSG Events in April
Share Article
Catalent, a global leader in clinical supply services, today announced that a number of its clinical supply experts will be participating in upcoming Global Clinical Supplies Group (GCSG) events, discussing cell and gene therapy supply chains, direct-to-patient (DTP) services, and just-in-time delivery models. SOMERSET, N.J. (PRWEB) April 07, 2021 Catalent, a global leader in clinical supply services, today announced that a number of its clinical supply experts will be participating in upcoming Global Clinical Supplies Group (GCSG) events, discussing cell and gene therapy supply chains, direct-to-patient (DTP) services, and just-in-time delivery models.